277. Outcomes After Image-guided Radiofrequency Ablation for Treatment of Stage I NSCLC in High-risk Patients by a Thoracic Surgical Service in More than 100 patients: Analysis of Prognostic Variables

Hiran C Fernand

FRCS, FRCSEd, FACS

Dr Hiran Fernando is currently the Director of Thoracic Surgery at Allegheny General Hospital, Pittsburgh and a Professor of Surgery at Drexel University. After obtaining fellowships from the Royal College of Surgeons of England and Edinburgh, he undertook additional training in the United States. He previously held faculty appointments at the University of Pittsburgh, Boston University, Virginia Commonwealth University (at the Inova Fairfax medical Campus) before joining the faculty at Allegheny General Hospital.  His clinical interests include lung cancer, esophageal cancer and benign esophageal diseases with a focus on minimally invasive approaches for these diseases. He has published extensively in these areas serving as the principal or co-principal investigator for several multi-center clinical trials.  He is a member of several societies including the AATS, STS, American Surgical Association, ISMICS, ESTS, and the General Thoracic Surgery Club.  He is an Associate Editor for Diseases of the Esophagus and has served on the Editorial Board of the Annals of Thoracic Surgery. He has been a co-author for several guidelines sponsored by the STS and ISMICS.

Ian Christie is currently a resident at UPMC Medical Education in their integrated cardiothoracic residency in the thoracic surgery tract.  Ian attended medical school at the University of Pittsburgh.  Ian is interested in thoracic oncology, benign foregut, and lung failure and transplantation.